Sweden vs Switzerland: Previously treated cases tested for RR-/MDR-TB
Sweden
50.0%
in 2024
Switzerland
48.0%
in 2024
Sweden rank
150th
Switzerland rank
153rd
Previously treated cases tested for RR-/MDR-TB over time
- Sweden
- Switzerland
How they compare
Sweden currently reports 50.0% against 48.0% in Switzerland, a difference of 2.0%.
The two have swapped places 9 times across 20 shared years of data; in 2005 it was Switzerland ahead.
Sweden ranks 150th and Switzerland ranks 153rd of 180 countries.
Across the 3 decades both report, Sweden averaged higher in 2 and Switzerland in 1.
Head to head by decade
| Decade | Sweden | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.6% | 73.0% | 1.6% | Sweden |
| 2010s | 63.0% | 64.4% | 1.4% | Switzerland |
| 2020s | 71.0% | 36.6% | 34.4% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sweden or Switzerland?
- Sweden, at 50.0% against 48.0% in Switzerland as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sweden and Switzerland?
- 2.0%, with Sweden ahead.
- How many years of comparable data are there for Sweden and Switzerland?
- 20 years are reported by both, from 2005 to 2024.
- How do Sweden and Switzerland rank globally for previously treated cases tested for rr-/mdr-tb?
- Sweden ranks 150th and Switzerland ranks 153rd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.